switching glp 1 MCT2D Patients without diabetes who switched

Articles were identified through combinations of keywords including probiotics, prebiotics, synbiotics, gut-brain axis, and neurocognitive health

*These findings show an association between stopping GLP-1 RAs and these outcomes, but not a causation

Silva may divide your weekly dose into two smaller injections, delivering the same total amount in a gentler, more tolerable pattern

It may also result from an imbalance in the intestinal ecosystem

Understanding this timeline helps set realistic expectations and keeps you motivated as your body responds to GLP-1 therapy

Click here to contact KFF Health News' reporting team